top of page

Insights Archive

Highlights Q1 2023

Chronic Limb Threatening Ischemia
Pharma Commercialization Services
Intraoperative Molecular Imaging
Laparoscopic Surgery
Smart Abdominal Binder
Digital Health – Remote Patient Monitoring
Protein Characterization
Clinical Research Organization
Senior Living

Digital Health Review 2022

This report provides a review of revenue performance of public companies in FSI’s Digital Health segments in 2022 as compared to previous years. Inside you will find FSI’s view of key trends from leading Digital Health companies and those investing in Digital Health (Medtech, the Big Four Tech, and Payors), as well as analysis of Digital Health VC investments, M&A, and IPOs

Life Science Tools and Diagnostics Review 2022

This report provides a review of revenue growth for public companies in FSI’s Life Science Tools and Diagnostics segments in 2022 as well as US investments and exits

Medtech Review 2022

This report provides a review of revenue growth for public companies in FSI’s Medtech segments in H2 2022 as well as US Medtech investments and exits

Peripheral Vascular (PV) Device Review 2022

This report highlights FSI's Peripheral Vascular (PV) Device Review. Inside you will find the following:

- Revenue performance of key public companies, as well as peripheral vascular M&A and investments through 2022
- FSI’s view of key trends from leading companies in the PV space and those investing in peripheral vascular - devices
- Analysis of VC investments in select PV device segments, as well as M&A activity and IPOs

Highlights H2 2022

Microbiome Consumables and Services
Pulmonary Testing
Clinical Research Organization
Sleep Apnea Device
Oncology CRO
Pharma Clinical Trial Logistics
Academic Medical Center
Pharma Commercialization Services
Digital Health Staffing Solution
Clinical Research Organization
Heath System Innovation Group
Academic Medical Center
Women's Health
Novel Surgical Device Diligence
Home Care Digital Health Solution

Cardiovascular Device Review 2022

This report highlights FSI's Cardiovascular Device Review of 2022. Inside you will find the following:

- Revenue performance of key public companies, as well as cardiovascular M&A and investments through 2022 
- FSI’s view of key trends from leading cardiovascular device companies and those investing in cardiovascular devices  
- Analysis of VC investments in select cardiovascular device segments, as well as M&A activity and IPOs

Robotic Assisted Surgery Review 2022

This report highlights the analysis of the Robotic Assisted Surgery (RAS) Landscape in 2022. Inside you will find the following:

- FSI’s unique framework used to analyze 128 RAS platforms
- Product development stage and funding status of 110 RAS companies
- Key trends from medtech executives and hospital perspective along with
challenges and opportunities for companies and investors
- Analysis of VC investments and M&A in RAS

Digital Health Review H1 2022

This report highlights performance of the Digital Health segment in the first half of 2022 as compared to previous years, as well as investments and exits.
Included are public company revenue performance in key segments such as Telehealth and Healthcare IT, as well as analyses of Digital Health VC investments, M&A, and IPOs.

Spotlight on Decentralized Clinical Trials 2022

FSI's views on investments in the DCT space, regulatory trends, and applicability by therapeutic area shed light on how this emerging approach to clinical development will be adopted by industry.

Medtech Review H1 2022

This report provides a review of revenue growth for public companies in FSI’s Medtech segments from 2019 – H1 2022
as well as US Medtech investments and exits. Inside you will find:
- Revenue performance of public companies in key segments such as cardiovascular / peripheral vascular,
diagnostics, life science tools, orthopedics, and diversified companies
- Overview of US VC investments, M&A, and IPOs in medical devices/supplies and diagnostics/life science tools

Highlights Q2 2022

Life Science Tools
Respiratory Devices
FemTech
Laser Ablation
Medical Imaging
Health System Pharmacy
Molecular Diagnostics
Bioprocessing
Pharma Sales
Gynecologic Devices
Health System Cost Cycle Management
Senior Living

Highlights Q1 2022

Prostate Cancer
Intraoperative Diagnostics
Clinical Research Organization
Renal Replacement Therapy
Medical Device Reprocessing
Trigeminal Neuralgia
Innovation Banking
Neurosurgical Devices
Electric Vehicle Charging Infrastructure

Highlights Q4 2021

Innovation Banking
Neuropathic Pain Analgesic
Medtech Acquisition Target Search
Digital Health - AI-Enabled Cancer Detection
Pharma Commercialization Services
Clinical Research Organization
Senior Living Brand Positioning
Senior Living Post-Merger Integration
Neurosurgical Instruments
In-Office ENT Procedure Solutions
Durable Medical Equipment
Academic Medical Center
Digital Health
Mitral Regurgitation
Utilities Construction Services

Highlights Q3 2021

Investor Presentation for Series B Fundraise
Cardiac Imaging
Biopharma Commercialization
Digitial Health
Academic Medical Center
Enzyme Therapy for Diabetes
Patient Monitoring
Senior Living
Medical Device Contract Manufacturer
Remote Sample Collection for PCR Diagnostics

Highlights Q2 2021

Point of Care Ultrasound
Robotic Surgery Assistant
Academic Medical Center
Bioprocessing
Cardiac Monitoring
Digital Health
DNA Testing and PPE
Robotic surgery development trends
Real-time surgical visualization

Highlights Q1 2021

Medtech Acquisition Search
Aesthetic Medicine
Clinical Trial Services
AI-powered Imaging Diagnostic Tool
Cardiac Monitoring
Imaging Core Lab
Women's Health
AI-powered Imaging Diagnostic Tool in Women's Health
Academic Medical Center - Research
Academic Medical Center - Commercialization
Academic Medical Center - Innovation Fund

Highlights Q4 2020

Novel Biologics Platform Technology
Laparoscopic Surgery
Operating Room Integration in the EU
AMC Physicians’ Organization
Downstream Bioprocessing for COVID 19
Home and Community Based Medicaid Services
Virtual Clinical Trials
Women's Health
Teledentistry
Downstream Bioprocessing
PharmaMedical Communications
Investment Fund Operating Plan

Highlights Q3 2020

GYN Surgical Robot
Gene and Cell Therapy Bioprocessing
Academic Medical Center Research
Infectious Disease Therapeutics
Specialty CRO
Operating Room Integration
Distribution of Surgical Products
Pharma Contract Research Services
AMC Physician Organization
Healthcare Research
Lung Cancer Treatment
Cloud-Based Document Management
Pediatric Clinical Nutrition Analytics

Highlights Q2 2020

COVID-19
Surgical Robotics
Outsourced Services for Biopharma
Telehealth
Outsourced Engineering Services
Organizational Effectiveness
Research Prioritization
Surgical Dressings
Robotic Omni-channel Fulfillment
Regulatory Consulting

bottom of page